Over a quarter of nursing homes reported serious deficiencies in 2026, with 5% tied to actual harm, according to a recent survey. The findings raise concerns about safety and quality of care for residents in skilled nursing facilities.

Research shows dementia is the most expensive diagnosis in retirement, yet Medicare covers almost none of the associated costs. At the same time, a comparison of Medicaid and Medicare payment rates for vitreoretinal surgeries highlights ongoing reimbursement challenges for specialty care.

Developers are moving forward with large‑scale senior housing projects, including Wellpointe’s $2 billion affordable campus in Los Angeles and new memory‑care sales in San Diego. Meanwhile, legislative efforts to block AI‑driven prior authorization in Medicare have stalled, keeping the policy in place.